🧬 High-Throughput Innovation & Breaking Biotech Bottlenecks | Judy Chou (Part 2/4)

Episode notes

The Biotech Startups Podcast is powered by Excedr —helping life science startups accelerate R&D and commercialization with founder-friendly equipment leasing. Skip the upfront costs, stay lean, and focus on breakthrough science. As a TBSP listener, you can get exclusive perks through Excedr’s partner network—special savings, promotions, and more. Explore these offers today: . "Don't go where the path may lead you. Instead, go where there's no path and leave a trail." In this episode of The Biotech Startups Podcast, President & CEO of AltruBio, Judy Chou, shares her pivotal transition from academia to industry, revealing how she left AbbVie when the company went idle after Humira's launch to pursue more meaningful work at Wyeth. Despite Humira becoming one of the most successful drugs in history, the company's uncertainty about biologics left Judy feeling unable to fulfill her mission to make a difference for patients. Judy describes how she pioneered high-throughput screening for biologics at Wyeth, earning the nickname "High-Throughput Lady" when colleagues thought her ideas were crazy.